JRCT ID: jRCT2031220115
Registered date:04/06/2022
General Drug Use-results Survey of Rituxan Intravenous infusion - Refractory Pemphigus Vulgaris and Pemphigus Foliaceus -
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | pemphigus vulgaris and pemphigus foliaceus |
| Date of first enrollment | 04/06/2022 |
| Target sample size | 125 |
| Countries of recruitment | |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Incidence of adverse events and adverse drug reactions. PDAI activity score, Clinical global impression-improvement, patient global impression-improvement. |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | Patients with refractory pemphigus vulgaris and pemphigus foliaceus who have received Rituxan intravenous infusion. |
| Exclude criteria | none |
Related Information
| Primary Sponsor | Ando Takashi |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Junko Sakamoto |
| Address | 6-15, Otsuka 5-chome, Bunkyo-ku, Tokyo Tokyo Japan 112-8650 |
| Telephone | +81-3-3946-1136 |
| Junko_Sakamoto@mail.zenyaku.co.jp | |
| Affiliation | Zenyaku Kogyo, Co., LTD. |
| Scientific contact | |
| Name | Takashi Ando |
| Address | 6-15, Otsuka 5-chome, Bunkyo-ku, Tokyo Tokyo Japan 112-8650 |
| Telephone | +81-3-3946-1136 |
| Takashi_Ando@mail.zenyaku.co.jp | |
| Affiliation | Zenyaku Kogyo, Co., LTD. |